[1] | Ge HY , Liu KJ , Juan T , Fang F , Newman M , Hoeck W . FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution. Bioinformatics, 2011, 27( 14): 1922- 1928. | [2] | Gerstein MB , Bruce C , Rozowsky JS , Zheng DY , Du J , Korbel JO , Emanuelsson O , Zhang ZD , Weissman S , Snyder M . What is a gene, post-ENCODE? History and updated definition. Genome Res, 2007, 17( 6): 669- 681. | [3] | Gingeras TR . Implications of chimaeric non-co-linear transcripts. Nature, 2009, 461( 7261): 206- 211. | [4] | Rowley JD . Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature, 1973, 243( 5405): 290- 293. | [5] | Skapek SX , Anderson J , Barr FG , Bridge JA , Gastier- Foster JM , Parham DM , Rudzinski ER , Triche T , Hawkins DS . PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report. Pediatr Blood Cancer, 2013, 60( 9): 1411- 1417. | [6] | Missiaglia E , Williamson D , Chisholm J , Wirapati P , Pierron G , Petel F , Concordet JP , Thway K , Oberlin O , Pritchard-Jones K , Delattre O , Delorenzi M , Shipley J . PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. J Clin Oncol, 2012, 30( 14): 1670- 1677. | [7] | Jothi M1, Mal M, Keller C, Mal AK. Small molecule inhibition of PAX3-FOXO1 through AKT activation suppresses malignant phenotypes of alveolar rhabdomyosarcoma. Mol Cancer Ther, 2013, 12( 12): 2663- 2674. | [8] | Loupe JM , Miller PJ , Ruffin DR , Stark MW , Hollenbach AD . Inhibiting phosphorylation of the oncogenic PAX3- FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy options. Oncogenesis, 2015, 4( 3): e145. | [9] | Williamson D , Missiaglia E , De Reyniès A , Pierron G , Thuille B , Palenzuela G , Thway K , Orbach D , Laé M , Fréneaux P , Pritchard-Jones K , Oberlin O , Shipley J , Delattre O . Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol, 2010, 28( 13): 2151- 2158. | [10] | Tognon C , Knezevich SR , Huntsman D , Roskelley CD , Melnyk N , Mathers JA , Becker L , Carneiro F , MacPherson N, Horsman D, Poremba C, Sorensen PHB. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell, 2002, 2( 5): 367- 376. | [11] | Persson M , Andrén Y , Mark J , Horlings HM , Persson F , Stenman G . Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA, 2009, 106( 44): 18740- 18744. |
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
|
|
|